nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Flupentixol—ABCB1—adrenal gland cancer	0.0131	0.211	CrCbGaD
Zuclopenthixol—Domperidone—ABCB1—adrenal gland cancer	0.00884	0.142	CrCbGaD
Zuclopenthixol—Nefazodone—ABCB1—adrenal gland cancer	0.00734	0.118	CrCbGaD
Zuclopenthixol—Trazodone—ABCB1—adrenal gland cancer	0.00679	0.109	CrCbGaD
Zuclopenthixol—Fluphenazine—ABCB1—adrenal gland cancer	0.0055	0.0882	CrCbGaD
Zuclopenthixol—Chlorprothixene—ABCB1—adrenal gland cancer	0.00501	0.0803	CrCbGaD
Zuclopenthixol—Trifluoperazine—ABCB1—adrenal gland cancer	0.0044	0.0705	CrCbGaD
Zuclopenthixol—Quetiapine—ABCB1—adrenal gland cancer	0.00426	0.0684	CrCbGaD
Zuclopenthixol—Clozapine—ABCB1—adrenal gland cancer	0.00367	0.0588	CrCbGaD
Zuclopenthixol—Chlorpromazine—ABCB1—adrenal gland cancer	0.00345	0.0553	CrCbGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00135	0.00144	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00135	0.00144	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00135	0.00144	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00134	0.00143	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00133	0.00142	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00133	0.00142	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00133	0.00142	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00133	0.00141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00133	0.00141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00131	0.00139	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0013	0.00139	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00126	0.00135	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00126	0.00135	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GNRH1—adrenal gland cancer	0.00125	0.00133	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00124	0.00133	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00124	0.00132	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.00124	0.00132	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00124	0.00132	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00123	0.00131	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00123	0.00131	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00123	0.00131	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00122	0.0013	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00121	0.0013	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00121	0.00129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00121	0.00129	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00121	0.00129	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00121	0.00129	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00121	0.00129	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0012	0.00128	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00119	0.00126	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00118	0.00126	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00118	0.00126	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00117	0.00124	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00117	0.00124	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00116	0.00124	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00116	0.00124	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00116	0.00123	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CDC42—adrenal gland cancer	0.00115	0.00123	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPRY2—adrenal gland cancer	0.00114	0.00122	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00114	0.00122	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00113	0.0012	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.00112	0.0012	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TSHR—adrenal gland cancer	0.00111	0.00119	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.00111	0.00119	CbGpPWpGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	0.0011	0.00117	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0011	0.00117	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.0011	0.00117	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—GNAS—adrenal gland cancer	0.0011	0.00117	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00109	0.00116	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00108	0.00115	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00106	0.00113	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00105	0.00112	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MEN1—adrenal gland cancer	0.00105	0.00112	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00104	0.00111	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00104	0.00111	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00103	0.0011	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.00102	0.00109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.00102	0.00109	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000989	0.00105	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000985	0.00105	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.00096	0.00102	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—POMC—adrenal gland cancer	0.000957	0.00102	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000945	0.00101	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000936	0.000998	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000923	0.000985	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000921	0.000983	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000921	0.000982	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.000919	0.00098	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000904	0.000964	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000902	0.000962	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000902	0.000962	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00088	0.000939	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CDC42—adrenal gland cancer	0.000879	0.000938	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000866	0.000924	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000864	0.000922	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000848	0.000904	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF2—adrenal gland cancer	0.000847	0.000904	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—GNAS—adrenal gland cancer	0.00084	0.000896	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000838	0.000894	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000832	0.000887	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000822	0.000877	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000819	0.000874	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—POMC—adrenal gland cancer	0.000814	0.000868	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000813	0.000867	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000809	0.000863	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000807	0.000861	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PRKACA—adrenal gland cancer	0.0008	0.000853	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.0008	0.000853	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000798	0.000851	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000792	0.000845	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000788	0.00084	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000786	0.000838	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000783	0.000835	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000773	0.000824	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000771	0.000823	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.000763	0.000814	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000757	0.000807	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000747	0.000796	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000743	0.000793	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—POMC—adrenal gland cancer	0.000739	0.000788	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000736	0.000785	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000735	0.000783	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000733	0.000782	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000731	0.00078	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00073	0.000778	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000728	0.000776	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000724	0.000773	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000719	0.000767	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000716	0.000764	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000713	0.000761	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000713	0.00076	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000711	0.000759	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TERT—adrenal gland cancer	0.000705	0.000752	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000703	0.00075	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000702	0.000749	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000701	0.000747	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.0007	0.000747	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000698	0.000744	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000689	0.000734	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000687	0.000733	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000681	0.000726	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CDC42—adrenal gland cancer	0.000679	0.000724	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.00067	0.000715	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.000669	0.000713	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000668	0.000713	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000667	0.000711	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000667	0.000711	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000665	0.00071	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000656	0.0007	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF2—adrenal gland cancer	0.000654	0.000698	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000648	0.000692	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GNAS—adrenal gland cancer	0.000648	0.000692	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000639	0.000681	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000636	0.000678	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1R—adrenal gland cancer	0.000632	0.000674	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—BAD—adrenal gland cancer	0.000614	0.000654	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.00061	0.00065	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000584	0.000623	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—POMC—adrenal gland cancer	0.000566	0.000603	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000563	0.0006	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	0.000559	0.000596	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000558	0.000595	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000557	0.000594	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TERT—adrenal gland cancer	0.000544	0.000581	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000544	0.000581	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000541	0.000577	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000529	0.000564	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00052	0.000555	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00052	0.000555	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000519	0.000554	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000512	0.000546	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00051	0.000544	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00051	0.000543	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000501	0.000534	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000497	0.00053	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.00048	0.000512	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—BAD—adrenal gland cancer	0.000474	0.000505	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000473	0.000505	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000473	0.000504	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000472	0.000503	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000469	0.0005	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000465	0.000496	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000463	0.000494	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000451	0.000481	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000443	0.000472	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000441	0.00047	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—adrenal gland cancer	0.000437	0.000466	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000434	0.000463	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000433	0.000462	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	0.000431	0.00046	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.00043	0.000459	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000425	0.000453	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000425	0.000453	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000421	0.000449	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000418	0.000446	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	0.000418	0.000446	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000417	0.000445	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000415	0.000442	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000414	0.000441	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000411	0.000438	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00041	0.000437	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000408	0.000435	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000406	0.000433	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000404	0.000431	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000404	0.000431	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000404	0.00043	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000396	0.000422	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000395	0.000421	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000381	0.000406	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000377	0.000402	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000376	0.000401	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000371	0.000396	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000368	0.000392	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000363	0.000387	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00036	0.000384	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000356	0.000379	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000354	0.000377	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000348	0.000371	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000347	0.00037	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000341	0.000364	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	0.00032	0.000341	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000317	0.000338	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000312	0.000332	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000308	0.000328	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000304	0.000324	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000303	0.000323	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000302	0.000322	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000297	0.000316	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000294	0.000314	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000288	0.000308	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000284	0.000303	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.00028	0.000299	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000279	0.000298	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000279	0.000297	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000276	0.000294	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000276	0.000294	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000275	0.000293	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000273	0.000292	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000272	0.00029	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.00027	0.000288	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—adrenal gland cancer	0.000269	0.000286	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000268	0.000286	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000267	0.000285	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000267	0.000284	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000262	0.000279	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000254	0.000271	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000251	0.000267	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	0.000247	0.000263	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000243	0.000259	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000242	0.000258	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000212	0.000227	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—adrenal gland cancer	0.000207	0.000221	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000202	0.000216	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000199	0.000213	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000199	0.000212	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000198	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000195	0.000208	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000181	0.000193	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000178	0.00019	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	0.00016	0.000171	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000158	0.000168	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000158	0.000168	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.000158	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000155	0.000165	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000144	0.000153	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—adrenal gland cancer	0.000135	0.000144	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	0.000133	0.000141	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—adrenal gland cancer	0.000132	0.000141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.00013	0.000138	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000121	0.000129	CbGpPWpGaD
